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Abstract
Background: Myocardial perfusion scintigraphy (MPS) is an important diagnostic tool in the 
management of patients with suspected coronary artery disease (CAD). However, the presence 
of mild-moderate perfusion defects can be challenging and may lead to unnecessary cardiac 
catheterization. The coronary artery calcium (CAC) score is a method with excellent negative 
predictive value in the evaluation of CAD, but its role in this setting of patients has not been 
fully defined. This study aims to assess the potential of CAC in the prediction of cardiac adverse 
events in patients with suspected CAD with mild-moderate perfusion by MPS.
Methods and results: We conducted a cohort study in 292 patients presenting with mild-
-moderate perfusion defects by MPS undergoing a CAC measurement. The patients were 
followed for a mean of 34 months for occurrence of major cardiac adverse events (MACE). 
The majority of the patients (64.7%) were male, mean age of 57.9 ± 12.6 years. During the 
follow-up there were 37 MACE. In multivariate Cox proportional hazards model, hypertension 
and CAC were independent predictors of MACE. The patients who presented a CAC score of  
≥ 400 had a high risk of MACE (HR 20.9; 95% CI 4.79–91.42; p < 0.001). Kaplan-Meier curve 
showed a significant difference (log-rank c2; p< 0.001) using CAC scores in predicting MACE.
Conclusions: CAC score carries a powerful prognostic value in predicting adverse events in 
patients with suspected CAD and MPS with mild-moderate perfusion defects and may be use-
ful in risk stratification of these patients. (Cardiol J 2015; 22, 3: 330–335)
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Introduction
Coronary artery disease (CAD) is an impor-
tant cause of mortality and morbidity worldwide, 
with important socio-economic impacts [1]. The 
diagnosis of CAD takes into account the presence 
of symptoms, risk factors and complementary 
diagnostic methods that generally use stress 
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mecha nisms, with the goal of diagnosing the pres-
ence of myocardial ischemia. Among these, myo-
cardial perfusion imaging (MPI) using single pho-
ton emission computed tomography (SPECT) plays 
an important role in the diagnosis and prognosis of 
CAD. However, the occurrence of positive results 
may be due to various clinical situations beyond 
obstructive coronary atherosclerosis [2]. SPECT 
studies with non-significant perfusion defects for 
myocardial ischemia may represent a challenge, 
sometimes leading to unnecessary indication for 
cardiac catheterization. A recent multicenter study 
demonstrated that, based on current algorithms 
used for the evaluation of patients with suspected 
CAD, about 40% of patients undergoing coronary 
arteriography showed no coronary obstruction 
[3]. Coronary computed tomography angiography 
(CCTA) is an important method in the evaluation 
of the coronary arteries with high accuracy in the 
diagnosis and prognosis of coronary heart disease. 
Although coronary artery calcium (CAC) scoring 
has an established role in risk-stratifying asymp-
tomatic patients at intermediate risk of CAD, its 
utility in the evaluation of this specifically group 
is uncertain [4–9]. The purpose of this study is to 
assess the potential of CAC in the prediction of 
cardiac adverse events in patients with suspected 
CAD with mild-moderate perfusion by MPI.
Methods
From January 2008 to July 2013, 804 consecu-
tive patients with suspected CAD, who underwent 
CCTA were prospectively enrolled.
Among them, 292 patients had SPECT with 
non-significant perfusion deficit (defined as 
a summed stress score [SSS] between 4 and 12) 
and were selected for this study. The exclusion cri-
teria were: known CAD, acute coronary syndrome, 
cardiac arrhythmia, allergy to iodinated contrast 
material and renal failure. 
Informed consent was obtained from all pa-
tients and the Ethics Committee of the institution 
approved the study.
Upon admission, each individual completed 
a collection of standardized data on the presence 
of cardiac risk factors. Systemic arterial hyperten-
sion was defined as a documented history of high 
blood pressure or treatment with antihypertensive 
medications. Diabetes mellitus was defined by 
a diagnosis of diabetes formerly carried out by 
a physician and/or use of insulin or oral insulin-
lowering medication. Dyslipidemia was defined 
as known dyslipidemia or current treatment with 
lipid-lowering medication. A positive history of 
smoking was defined as smoking or smoking ces-
sation within 3 months of the examination. Family 
history of coronary heart disease was defined as the 
presence of CAD in first-degree relatives younger 
than 55 (men) or 65 (women) years of age.
Cardiac CT imaging protocol
All CT scans were performed on a 64-slice 
scanner with a 0.4 s rotation time (Aquilion mul-
ti-64-slice system, Toshiba Medical Systems). 
Non-enhanced CT scan for calcium scoring was 
performed from the level of tracheal bifurcation 
to the diaphragm using the following parameters: 
120 KVp, 300 mA, 0.25 s, slice thickness of 3 mm, 
and intervals of 3 mm. The calcium scores of each 
area at each vessel were calculated at an offline 
commercially available workstation with dedicated 
software (Software Vitrea 2 V3.9.0.1, MN, USA) 
and the scores were quantified by the scoring algo-
rithm proposed by Agatston et al. [10], and calcium 
scores were classified into the following categories: 
0 = 0; 1 = 1–99; 2 = 100–399 and 3 ≥ 400.
Patient adverse clinical outcomes were obtained 
through telephone interviews and were classified as 
the occurrence of: 1) cardiac death, 2) myocardial 
infarction or 3) need of revascularization.
Statistical analysis
The demographic and clinical characteristics of 
the study population were expressed as numbers 
and percentages for categorical variables and as 
mean and standard deviation for continuous vari-
ables. The variables were compared using c2 test 
for categorical variables and Student’s t-test for 
continuous variables. To satisfy the assumption 
that the events are independent, the recurrence of 
cardiac events in one participant was not included 
in the analysis.
Cox regression model was used to assess the 
value of clinical variables and CAC in predicting 
cardiac events. Initially, the univariable analysis of 
clinical characteristics and CAC measurement was 
performed to identify potential predictors. Hazard 
ratios (HR) were calculated with a 95% confidence 
interval (CI) as an estimate of risk associated with 
a particular variable. Subsequently, the multivari-
able analysis was performed including all variables 
selected in the univariate analysis. Cumulative 
event-free survival rates as a function over time 
were obtained by the Kaplan-Meier method. Car-
diac event-free survival curves were compared 
using the log-rank test. Statistical analyses were 
performed using the SPSS software (version 18.0, 
SPSS Inc., Chicago, Illinois) and p < 0.05 was 
considered statistically significant.
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Results
At enrollment, 334 patients were initially se-
lected, but 16 were excluded for indication of post-
coronary artery bypass grafting (CABG) surgery 
and 26 for post-angioplasty evaluation. In total, 292 
consecutive patients were included in the study; 
64.7% were men, with a mean age of 57.9 ± 12.6 
years. The general characteristics of the patients 
are summarized in Table 1. The indications for MPI 
assessment were as follows: evaluation of chest 
pain in 95 (32.5%) patients, positive stress test in 
97 (33.2%); asymptomatic patients with 2 or more 
risk factors in 79 (27%) patients, and other causes 
in 21 (7.2%) patients.
CAC score of 0 was presented in 45.5% of the 
patients, 1–100 score in 26.7%, 101–400 score in 
14.4% and 13.4% had CAC score more than 400. 
CAC 0 score had negative predictive value (NPV) 
of 97.5% for non-occurrence of events.
Mean follow-up was 34 (range 3–66) months, 
carried out in 264 (90.1%) patients. To determine 
whether loss at follow-up would influence the 
results, we performed a comparative analysis 
between the groups with and without follow-up, 
and no differences regarding age, sex, smoking 
status, hypertension, family history, dyslipidemia 
and diabetes were found.
A total of 37 events occurred during the fol-
low-up and only those with adverse clinical out-
comes occurring at least 3 months after follow-
up were selected. Three patients died of cardiac 
cause, myocardial infarction occurred in 9 patients; 
25 patients underwent coronary revascularization, 
with percutaneous coronary intervention being 
performed in 23 patients, while the remaining 
2 patients underwent CABG. The decision for re-
vascularization was based on worsening of angina 
and/or ischemia at noninvasive testing. Univariate 
analysis of clinical characteristics and at CCTA to 
predict adverse clinical outcomes is shown in Table 1. 
Variables that were significant in the univariate 
analysis were included in the multivariate analysis. 
Independent predictors of cardiac events obtained in 
the multivariate analysis are shown in Table 2.
In multivariate Cox proportional hazards 
model, CAC and hypertension were independent 
predictors of major cardiac adverse events (MACE; 
Table 3). A CAC score of ≥ 400 was associated with 
a high risk of MACE (HR 20.9; 95% CI 4.79–91.42; 
p < 0.001).  Kaplan-Meier curve (Fig. 1) showed 
a significant difference (log-rank c2; p < 0.001) us-
ing CAC scores in predicting MACE. Event-free 
survival rate at 1, 2 and 4-year follow-up was 99%, 
95% and 95% in patients with CAC 0–99 (groups 0 
and 1), in comparison with 97%, 83%, and 49% in 
those who had a CAC ≥ 400 (group 3).
Table 1. Baseline characteristics of the study 
population.
Age [years] 57.9 ± 12.6
Male sex 157 (64%)
Smoking 88 (30.1%)
Hypertension 169 (57.9%)
Diabetes mellitus 57 (19.5%)
Dyslipidemia 179 (61.3%)
Familial history 170 (58.2%)
Coronary artery calcium score:
0 133 (45.5%)
1–99 78 (26.7%)
100–399 39 (13.4%)
≥ 400 42 (14.4%)
Table 2. Baseline characteristics of the study population according to the occurrence of cardiac events.
Baselines values Patients without  
events (n = 266)
Patients with  
events (n = 37)
Hazard ratio (95% 
 confidence interval)
P
Age [years] 56.8 ± 12.3 65.8 ± 13.1 1.013 (1.009–1.064) 0.008
Male 144 (63%) 26 (70%) 0.743 (0.364–1.515) 0.41
Tabagism 66 (28%) 13 (36%) 1.921 (0.960–3.843) 0.07
Dyslipidemia 135 (60%) 27 (75%) 1.885 (0.881–4.031) 0.10
Hypertension 120 (53%) 30 (83%) 4.476 (1.962–11.481) 0.000
Sedentarism 94 (41%) 13 (36%) 0.758 (0.374–1.534) 0.44
Diabetes 38 (17%) 12 (33%) 2.275 (1.128–4.589) 0.02
Family history 135 (60%) 16 (44%) 0.780 (0.397–1.532) 0.47
Coronary artery calcium score 1 63 (28%) 7 (19%) 3.050 (0.786–11.838) 0.107
Coronary artery calcium score 2 32 (14%) 9 (24%) 5.400 (1.416–20.591) 0.014
Coronary artery calcium score 3 15 (7%) 18 (49%) 18.715 (5.496–63.734) 0.000
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Discussion
In the present study, we found that CAC score 
poses an incremental value in the prognostic evalu-
ation of patients with MPI studies presenting non-
significant perfusion deficit and suspected CAD.
Since its introduction over 30 years ago, 
SPECT has become a mainstay for assessing di-
agnosis and prognosis of patients with suspected 
CAD [2]. For patients with normal results, the rate 
of cardiac death and myocardial infarction are less 
than 1%. More extensive and severe perfusion 
defects are associated with up to 5% of the annual 
cardiac events rates [11–13]. The last subset is 
decidedly of high risk and favors the use of ag-
gressive anti-ischemic therapy and consideration 
of coronary angiography and revascularization [14].
Patients with non significant perfusion defects 
(SSS < 13) represent a group at intermediate risk 
for the occurrence of adverse events, with rates 
1–3%. Hachamovitch et al. [15] in a study involving 
5,183 patients, followed by an average period of 
642 days, showed that the annual rate of myocardial 
infarction was 0.5% in normal examinations, 2.7% 
had mild perfusion deficit, 2.9% for moderate deficit 
and 4.2% when there was severe impairment by 
SPECT. Doukky et al. [16], in a study encompassing 
1,390 followed by an average period of 27 months 
demonstrated that patients with perfusion deficits 
in mild to moderate magnitude showed HR for 
adverse events of 2.3 (95% CI 1.1–4.7, p = 0.02). 
On the other hand, non significant perfusion defects 
may be related to various clinical situations, such 
as the presence of endothelial dysfunction (an early 
marker of CAD), arrhythmias and myocardial hy-
pertrophy without concomitant significant obstruc-
tive lesion, as well as a higher rate of equivocal 
studies due to attenuation artifacts, movement 
and gating, arrhythmias, conduction disturbances, 
errors of acquisition and post processing [17, 18]. 
Given these considerations, the medical approach 
towards this group of patients can be challenging, 
requiring strategies to enable better stratification 
of these patients.
In our study, except hypertension, the conven-
tional risk factors were not able to stratify these 
patients, which may be explained by their high 
prevalence, since the indication of SPECT is often 
associated to an intermediate pretest risk of CAD.
The presence of calcification in the coronary 
arteries is equivalent to the presence of athero-
sclerosis, which can be measured noninvasively 
using a CT [19]. The assessment of CAC is based 
on a non-contrast acquisition of a series of axial 
CT cuts with a 3 mm thickness covering the whole 
extension of the heart, with radiation doses from 
0.9 to 1.1 mSv, defined as a hyper attenuating injury 
with signal intensity above 130 HU and area of 
(at least 1 mm2). Several population studies have 
shown that CAC score correlates significantly with 
the occurrence of major cardiovascular events in 
the monitoring of medium and long term [20–23]. 
Its use as a diagnostic tool, however, is more 
controversial, and although it represents an ex-
cellent NPV in the exclusion of obstructive CAD 
(96–100%), its positive predictive value (PPV) is 
moderate, which has been shown by more recent 
Table 3. Multivariate logistic regression model for predicting cardiac events.
Variables Hazard ratio 95% confidence interval P
Hypertension 3.027 1.212–7.560 0.018
Coronary artery calcium score 0/1 4.531 0.939–21.850 0.06
Coronary artery calcium score 0/2 5.879 1.220–28.338 0.027
Coronary artery calcium score 0/3 20.909 4.789–91.420 0.000
Figure 1. Kaplan-Meier survival curves comparing 
event-free survival rates according to the coronary ar-
tery calcium score groups (0/1, 2 and 3).
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studies, particularly in younger patients or popu-
lations with a high prevalence of significant CAD. 
In addition to inappropriate PPV, CAC score also 
has insufficient NPV to exclude the presence of 
significant obstructive disease [19, 24].
Several studies have demonstrated the additive 
role of CCTA in patients undergoing SPECT. Abidov 
et al. [25] demonstrated the ability of re-stratification 
in patients with normal, abnormal or inconclusive 
SPECT regarding studies with normal coronary 
arteries, non-obstructive CAD and significant CAD 
(> 50% stenosis) by CCTA. In this study, c.a. 53% 
of patients with abnormal exams by scintigraphy 
showed normal coronary by CCTA. Cole et al. [26], 
in a study investigating 206 patients with SPECT 
showing non-significant perfusion abnormalities, 
as well as equivocal or inconclusive studies, have 
shown that only 32% of these patients underwent 
catheterization based on the results of the CCTA. 
However, this algorithm expresses a concern related 
to overexposure to radiation and a load of iodinated 
contrast, especially when patients are subjected to 
all 3 procedures (SPECT, CCTA and subsequent 
coronary angiography). Thus, the introduction of the 
CAC score, non-invasive method with low cost and 
radiation exposure and without contrast, may allow 
better diagnostic strategy in these patients. In our 
sample, the high NPV of the CAC score suggests that 
this method could be useful in prognostic stratifica-
tion of these patients.
Limitations of the study
Among the limitations of this study, we mention 
the low rate of events, as well as a wide spectrum of 
different conditions associated with the examination 
indication. The exam results have the potential to 
influence the decision of revascularization indication 
and can change the outcome in this study. However, 
we considered an adverse clinical outcome only 
those that occurred after 3 months of follow-up 
(mean 34 [range 3–66] months). After this period, 
the indication for CABG was based on clinical deci-
sion, according to established guidelines. Never-
theless, the results of exams may be a confounding 
factor, being associated with the revascularization 
outcome. Studies of MPI were referred from differ-
ent institutions, and this may be a cause of potential 
variability in the results. However, we believe that it 
may reflect the daily clinical practice more reliably 
in the real world. Furthermore, the study population 
was small, and studies performed on larger samples 
are clearly necessary to confirm these results.
Conclusions
In conclusion, CAC score carries a strong 
prognostic value in predicting adverse events in 
patients with suspected CAD and myocardial per-
fusion scintigraphy with mild-moderate perfusion 
defects and may be useful in risk stratification of 
these patients.
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